
Cohance Lifesciences Investor Relations Material
Latest events

Q4 24/25
Cohance Lifesciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cohance Lifesciences Limited
Access all reports
Suven Pharmaceuticals Limited is a pharmaceutical company engaged in the development, manufacturing, and supply of active pharmaceutical ingredients (APIs) and intermediates. The company primarily focuses on contract development and manufacturing services (CDMO) for global pharmaceutical companies, supporting drug discovery and commercial production. Its operations include process research, custom synthesis, and scale-up of complex molecules for use in various therapeutic areas. Suven Pharmaceuticals Limited serves clients across regulated and emerging markets. The company is headquartered in Hyderabad, India, and its shares are listed on the NSE.
Key slides for Cohance Lifesciences Limited


Q4 24/25
Cohance Lifesciences Limited


Q4 24/25
Cohance Lifesciences Limited
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
COHANCE
Country
🇮🇳 India